MULTIPLE MYELOMA

Latest News

Linvoseltamab/Bortezomib Shows Consistent Safety in Relapsed/Refractory Multiple Myeloma
Linvoseltamab/Bortezomib Shows Consistent Safety in Relapsed/Refractory Multiple Myeloma

June 13th 2025

Coordination Is Essential During and After Referral for CAR T in Myeloma
Coordination Is Essential During and After Referral for CAR T in Myeloma

June 11th 2025

Bridging and BCMA Exposure Impact Ide-Cel Outcomes in Multiple Myeloma
Bridging and BCMA Exposure Impact Ide-Cel Outcomes in Multiple Myeloma

June 9th 2025

BPd Combo Improves PFS & Response in High-Risk Relapsed/Refractory Myeloma
BPd Combo Improves PFS & Response in High-Risk Relapsed/Refractory Myeloma

June 8th 2025

More News